Thursday, February 10, 2022

Armata Pharmaceuticals Finds $45M

Marina Del Rey-based biotech startup Armata Pharmaceuticals says it has raised $45M in an investment in the publicly listed company. According to the company, it is selling common tock and warrants to Innoviva Strategic Opportunities, LLC, which is already the company' largest shareholder. The company said the funding will go to advance its clinical pipeline and strengthen its bacteriophage platform. The company ha a number of compounds, aimed at treating chronic Pseudomonas aeruginosa infections in people with cystic fibrosis and other areas.